SIRPB1 and Alzheimer disease: As microglia have become a central theme in our current understanding of AD progression, and this is backed up by genetic evidence, we show that the Aβ clearance activities can be therapeutically enhanced by modulating the TREM2/SIRPβ1/TYROBP signaling complex of the microglia.